U.S. markets closed

  • S&P Futures

    3,833.00
    -6.00 (-0.16%)
     

  • Dow Futures

    31,500.00
    +35.00 (+0.11%)
     

  • Nasdaq Futures

    12,561.00
    -102.75 (-0.81%)
     

  • Russell 2000 Futures

    2,192.70
    +3.00 (+0.14%)
     

  • Crude Oil

    67.65
    +1.56 (+2.36%)
     

  • Gold

    1,705.60
    +7.10 (+0.42%)
     

  • Silver

    25.66
    +0.37 (+1.48%)
     

  • EUR/USD

    1.1908
    -0.0017 (-0.14%)
     

  • 10-Yr Bond

    1.5540
    +0.0040 (+0.26%)
     

  • Vix

    24.66
    -3.91 (-13.69%)
     

  • GBP/USD

    1.3818
    -0.0010 (-0.07%)
     

  • USD/JPY

    108.4200
    +0.0380 (+0.04%)
     

  • BTC-USD

    50,572.14
    +1,354.36 (+2.75%)
     

  • CMC Crypto 200

    1,021.53
    +78.35 (+8.31%)
     

  • FTSE 100

    6,630.52
    -20.36 (-0.31%)
     

  • Nikkei 225

    28,926.03
    +61.71 (+0.21%)
     

$7.8 Billion Medical Magnetic Resonance Imaging (MRI) Technologies and Markets, 2025 by Architecture, Field Strength, Application, End User

·4 min read

DUBLIN, Jan. 15, 2021 /PRNewswire/ -- The "Medical Magnetic Resonance Imaging (MRI): Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo
Research and Markets Logo

The global market for MRI systems should grow from $6.2 billion in 2020 to $7.8 billion by 2025 with a compound annual growth rate (CAGR) of 4.8% for the period of 2020-2025.

This report serves as a guide to understand the medical MRI market extensively in terms of the science, revenues, technology innovations, key manufacturers, and the competitive landscape. In this report, the market estimates are provided considering new sales of MRI machines for human use only. The market estimates for used and refurbished MRI machines will be discussed in a different report.

This report provides an overview and the following information at a regional level for various categories and distribution shares in the market, as well as the competitive landscape

This report includes:

  • 49 tables

  • Detailed overview of the global markets and technologies for medical magnetic resonance imaging (MRI)

  • Country specific data and analysis for the United States, Canada, Mexico, Germany, U.K., France, China, India, Japan, South Korea, Middle East and Africa

  • Analyses of global market trends, with data from 2019, estimates for 2020, and projections of compound annual growth rates (CAGRs) through 2025

  • Segmentation of the global MRI systems market by geographical region, end user, type, field strength and application areas

  • Information on market dynamics such as drivers, restraints, opportunities, technological advancements and identification of growth inhibiting areas that affect the global market

  • Evaluation of current market trends, market size, market forecast, and technological advancements within the industry

  • Coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies

  • Assessment of vendor landscape and corporate-level profiles of key companies operating for MRI devices market, including Siemens Healthcare GmbH, Alltech Medical Systems, Philips Healthcare, Hitachi Medical Corp., and GE Healthcare

Key Topics Covered:

Chapter 1: Introduction

  • Intended Audience

  • Study Goals and Objectives

  • Reasons for Doing This Study

  • Scope of Report

  • Information Sources

  • Primary Research

  • Secondary Research

  • Methodology

  • Market Estimate

  • Geographic Breakdown

  • Analyst's Credentials

Chapter 2: Summary and Highlights

Chapter 3: Overview of MRI Devices

  • Definition of an MRI Device

  • History of MRI

  • MRI Process

  • Components of an MRI System

  • Types of MRI devices

  • By Architecture

  • By Field Strength

Chapter 4: Market Dynamics

  • Market Drivers

  • Increasing Demand for Advanced Imaging Technologies

  • Aging World: Increasing Need for Imaging Technology

  • Increasing Prevalence of Chronic Diseases

  • Increasing Healthcare Spending

  • Market Restraints

  • Regulatory Constraints

  • Declining Public Insurance Refunds

  • Macroeconomic Factors

  • Declining Helium Gas Reserves and Production

Chapter 5: Market Breakdown by Architecture

  • Overview

  • Global Market Shares of MRI Systems by Segment

  • Closed MRI Systems

  • Open MRI Systems

  • Extremity MRI Systems

Chapter 6: Market Breakdown by Field Strength

  • Overview

  • Significance of Magnetic Strength

  • Need for High Magnetic Field Strength

  • Market Segmentation

  • Market Analysis

Chapter 7: Market Breakdown by Application

  • Overview

  • Market Drivers

  • Market Segmentation by Application

  • Market Analysis

Chapter 8: Market Breakdown by End User

  • Overview and Market Segmentation

  • Market Analysis

Chapter 9: Market Breakdown by Region

  • Global Medical Device Industry Scenario

  • Global Market for MRI Systems by Region

  • North America

  • Asia-Pacific

  • Europe

  • RoW

Chapter 10: Competitive Landscape

  • Industry Scenario

  • Factors Controlling the Market

  • Market Opportunities

  • Cryogen-Free Pre-clinical MRI Scanners

  • Scope for Product Innovations

  • Emerging Markets: A Ray of Hope for Struggling Manufacturers

  • Market Share

  • Advantages of Leading Manufacturers

Chapter 11: Company Profiles

  • Alltech Medical Systems

  • Aurora Imaging Technology Inc.

  • Canon Medical Systems Corp.

  • Esaote Spa

  • Fonar Corp.

  • GE Healthcare

  • Hitachi Medical Corp.

  • Medonica Co. Ltd.

  • Neusoft Medical Systems Co. Ltd.

  • Philips Healthcare

  • Shenzhen Anke High-Tech Co. Ltd.

  • Siemens Healthcare GmbH

  • Time Medical Systems

For more information about this report visit https://www.researchandmarkets.com/r/3ahljb

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.


Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

Cision
Cision

View original content:http://www.prnewswire.com/news-releases/7-8-billion-medical-magnetic-resonance-imaging-mri-technologies-and-markets-2025-by-architecture-field-strength-application-end-user-301209214.html

SOURCE Research and Markets

Recommended Stories

  • The next stimulus check: What's still ahead, before you'll get your money?

    And will you even get a payment this time, under the new limits the president agreed to?

  • Joe Biden's stimulus check changes: Do you still qualify for $1,400?

    To win Senate passage, Biden agreed to make millions ineligible for the third checks.

  • Getting A Third Covid-19 Stimulus Check Just Got Tougher — But You Might Still Influence How Big Yours Is

    Congress is nearing passage of the third economic stimulus check it will send out to you and other taxpayers as part of its Covid-19 relief bill.

  • Oil Jumps Above $71 After Key Saudi Crude Terminal Attacked

    (Bloomberg) -- Brent oil surged above $71 a barrel after Saudi Arabia said the world’s largest crude terminal was attacked, although output appeared to be unaffected after the missiles and drones were intercepted.Futures in London jumped 2.6% after rising 4.9% last week. The kingdom said a storage tank at Ras Tanura in the country’s Gulf coast was targeted on Sunday by a drone from the sea. The terminal is capable of exporting roughly 6.5 million barrels a day -- nearly 7% of oil demand -- and, as such, is one of the world’s most protected installations.The assault follows a recent escalation of hostilities in the Middle East region after Yemen’s Houthi rebels launched a series of attacks on Saudi Arabia. The new U.S. administration has also carried out airstrikes in Syria last month on sites it said were connected with Iran-backed groups.Oil’s rally accelerated last week after Saudi Arabia and OPEC+ made a surprise pledge to keep output steady in April. The move prompted a raft of investment banks to raise their price forecasts, with Goldman Sachs Group Inc. estimating global benchmark Brent will top $80 a barrel in the third quarter.The broader market is also being supported by bullish Chinese export data and the outlook for U.S. stimulus. President Joe Biden is on the cusp of his first legislative win with the House ready to pass his $1.9 trillion Covid-19 relief plan, the second-biggest economic stimulus in American history.See also: Andurand Predicts Commodities Bull Run as Hedge Fund Soars 12%“It’s a perfect mix of bullish news at the moment,” said Warren Patterson, head of commodities strategy at ING Bank NV in Singapore. “It does seem that these attacks are picking up in frequency, so the market may need to price in some risk premium.”Brent’s prompt timespread at 71 cents a barrel in backwardation, a bullish market structure where the front-month contract trades higher than later shipments. It averaged 58 cents in backwardation last week.The Sunday attack is the most serious against Saudi oil installations since a key processing facility and two oil fields came under fire in September 2019, cutting oil production for several days and exposing the vulnerability of the Saudi petroleum industry. That assault was claimed by the Houthi rebels, although Riyadh pointed the finger at Iran.For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.

  • To get the next stimulus check, you may want to hustle with your taxes

    The bill that passed the Senate makes payments harder to get. Your tax return might help.

  • Cathie Wood’s New Tesla Target Price Is Coming Soon. Here’s Where It Might Land.

    ARK Investment founder Cathie Wood says her new Tesla price target is coming soon. What will it be? Barron's hazards a back-of-the-envelope guess.

  • IRS Initiates ‘Operation Hidden Treasure’ to Root Out Unreported Crypto Income

    “These transactions are not anonymous,” the IRS' national fraud counsel said. “We see you.”

  • Your auto insurance company owes you a COVID 'stimulus check,' new lawsuits say

    Class-action suits contend that insurers have been unfairly profiting from emptier roads.

  • Stock Futures Rise as Stimulus Checks Are Expected to Arrive Soon

    “Over 85% of American households will get direct payments of $1,400 per person,” Biden said over the weekend.

  • JPMorgan Bets on These 3 Stocks; Sees Over 50% Upside Potential

    It’s time to check in with the macro picture, to get an idea of just where markets are headed in the coming months. That’s what a JPMorgan global research team, headed up by Joyce Chang, has been doing. The JPM team starts by noting the sell-off in US Treasury bonds last week, pushing up yields as investors acted in response to inflationary fears. However, the rise in bond yields steadied on Friday, and Chang’s team does not believe that inflation is the great bugaboo it’s made out to be; her team sees a combination of economic growth and fiscal stimulus creating a virtuous circle of consumer spending fueling more growth. They write, “Our global economics team is now forecasting US nominal GDP to average roughly 7% growth over this year and next as targeted measures have been successful in addressing COVID-19 and economic activity is not being jeopardized. Global growth will exceed 5%...” What this means, in JPM’s view, is that the coming year should be good for stocks. Interest rates are likely to remain low, in the firm’s estimation, while inflation should moderate as the economy returns to normal. JPM’s stock analysts have been following the strategy team, and seeking out the stocks they see as winners over the next 12 months. Three of their recent picks make for an interesting lot, with Strong Buy ratings from the analyst community and over 50% upside potential. We’ve used the TipRanks database to pull the details on them. Let’s take a look. On24 (ONTF) The first JPM pick were looking at here is On24, the online streaming service that offers third parties access for scaled and personalized networked events. In other words, On24 makes its streaming service available for other companies to use in setting up interactive features, including webinars, virtual events, and multi-media experiences. The San Francisco-based company boasts a base of more than 1900 corporate users. On24’s customers engage online with more than 4 million professionals every month, for more than 42 million hours every year. As can be imagined, On24 saw a surge of customer interest and business in the past year, as virtual offices and telecommuting situations expanded – and the company has now used that as a base for going public. On24 held its IPO last month, and entered the NYSE on February 3. The opening was a success; 8.56 million shares were put on the market at $77 each, well above the $50 initial pricing. However, shares have taken a beating since, and have dropped by 36%. Nevertheless, JPM’s Sterling Auty thinks the company is well-placed to capitalize on current trends. “The COVID-19 pandemic, we believe, has changed the face of B2B marketing and sales forever. It has forced companies to move most of their sales lead generation into the digital world where On24 is typically viewed as the best webinar/webcast provider.” the 5-star analyst wrote. “Even post-pandemic we expect the marketing motion to be hybrid with digital and in-person being equally important. That should drive further adoption of On24-like solutions, and we expect On24 to capture a material share of that opportunity.” In line with these upbeat comments, Auty initiated coverage of the stock with an Overweight (i.e., Buy) rating, and his $85 price target suggests it has room for 73% upside over the next 12 months. (To watch Auty’s track record, click here.) Sometimes, a company is just so solid and successful that Wall Street’s analysts line up right behind it – and that is the case here. The Strong Buy analyst consensus rating is unanimous, based on 8 Buy-side reviews published since the stock went public just over a month ago. The shares are currently trading for $49.25 and their $74 average price target implies an upside of 50% from that level. (See On24’s stock analysis at TipRanks.) Plug Power, Inc. (PLUG) And moving over to the reusable energy sector, we’ll take a look at a JPM ‘green power’ pick. Plug Power designs and manufactures hydrogen power cells, a technology with a great deal of potential as a possible replacement for traditional batteries. Hydrogen power cells have potential applications in the automotive sector, as power packs for alt-fuel cars, but also in just about any application that involves the storage of energy – home heating, portable electronics, and backup power systems, to name just a few. Over the past year, PLUG shares have seen a tremendous surge, rising over 800%. The stock got an additional boost after Joe Biden’s presidential election win – and his platform promises to encourage ‘Green Energy.” But the stock has pulled back sharply recently, as many over-extended growth names have. Poor 4Q20 results also help explain the recent selloff. Plug reported a deep loss of $1.12 per share, far worse than the 8-cent loss expected, or the 7-cent loss reported in the year-ago quarter. In fact, PLUG has never actually reported positive earnings. This company is supported by the quality of its technology and that tech’s potential for adoption as industry moves toward renewable energy sources – but we aren’t there yet, despite strides in that direction. The share price retreat makes PLUG an attractive proposition, according to JPM analyst Paul Coster. “In the context of the firm's many long-term growth opportunities, we believe the stock is attractively priced at present, ahead of potential positive catalysts, which include additional ‘pedestal’ customer wins, partnerships and JVs that enable the company to enter new geographies and end-market applications quickly and with modest capital commitment,” the analyst said. “At present, PLUG is a story stock, appealing to thematic investors as well as generalists seeking exposure to Renewable Energy growth, and Hydrogen in particular.” Coster’s optimistic comments come with an upgrade to PLUG’s rating - from a Neutral (i.e., Hold) to Overweight (Buy) - and a $65 price target that indicates a possible 55% upside. (To watch Coster’s track record, click here.) Plug Power has plenty of support amongst Coster’s colleagues, too. 13 recent analyst reviews break down to 11 Buys and 1 Hold and Sell, each, all aggregating to a Strong Buy consensus rating. PLUG shares sell for $39.3 and have an average price target of $62.85, which suggests a 60% one-year upside potential. (See Plug’s stock analysis at TipRanks.) Orchard Therapeutics, PLC (ORTX) The last JPM stock pick we’ll look at is Orchard Therapeutics, a biopharma research company focused on the development of gene therapies for the treatment of rare diseases. The company’s goal is to create curative treatments from the genetic modification of blood stem cells – treatments which can reverse the causative factors of the target disease with a single dosing. The company’s pipeline features two drug candidates that have received approval in the EU. The first, OTL-200, is a treatment for Metachromatic leukodystrophy (MLD), a serious metabolic disease leading to losses of sensory, motor, and cognitive functioning. Strimvelis, the second approved drug, is a gammaretroviral vector-based gene therapy, and the first such ex vivo autologous gene therapy to receive approve by the European Medicines Agency. It is a treatment for adenosine deaminase deficiency (ADA-SCID), when the patient has no available related stem cell donor. In addition to these two EU-approved drugs, Orchard has ten other drug candidates in various stages of the pipeline process, from pre-clinical research to early-phase trials. Anupam Rama, another of JPM’s 5-star analysts, took a deep dive into Orchard and was impressed with what he saw. In his coverage of the stock, he notes several key points: “Maturing data across various indications in rare genetic diseases continues to de-risk the broader ex vivo autologous gene therapy platform from both an efficacy / safety perspective… Key opportunities in MLD (including OTL-200 and other drug candidates) have sales potential each in the ~$200-400M range… Importantly, the overall benefit/risk profile of Orchard’s approach is viewed favorably in the eyes of physicians. At current levels, we believe ORTX shares under-reflect the risk-adjusted potential of the pipeline...” The high sales potential here leads Rama to rate the stock as Outperform (Buy) and to set a $15 price target, implying a robust 122% upside potential in the next 12 months. (To watch Rama’s track record, click here.) Wall Street generally is in clear agreement with JPM on this one, too. ORTX shares have 6 Buy reviews, for a unanimous Strong Buy analyst consensus rating, and the $15.17 average price target suggests a 124% upside from the current $6.76 trading price. (See Orchard’s stock analysis at TipRanks.) Disclaimer: The opinions expressed in this article are solely those of the featured analysts. The content is intended to be used for informational purposes only. It is very important to do your own analysis before making any investment.

  • Ripple Investor’s Request to Reclaim Its $175M Investment Rejected by Court

    Tetragon lost its bid to reclaim its portion of a $200 million Series C investment in the blockchain company.

  • Why Cathie Wood Is Bullish On DraftKings

    Ark Funds CEO and Founder Cathie Wood joined Benzinga’s “Raz Report” this week and discussed the history of Ark Funds. Wood also shared some of the reasons why Ark Funds owns several positions, including in DraftKings Inc (NASDAQ: DKNG). Wood on DraftKings: Wood told Benzinga that DraftKings is becoming accepted as a platform for sports betting as the public grows more comfortable with the activity. “We do think sports betting is losing its taint,” Wood said. The fund manager sees more states turning toward legalizing sports betting, especially as many face huge deficits, Wood said. Wood used New Jersey as an example of the success states can have. The state is a mature market and DraftKings’ revenue was up 100% in the state. “New Jersey was very telling to us," she said. Ark Funds: DraftKings was added to two different Ark Funds beginning in February. Ark Next Generation Internet ETF (NYSE: ARKW) owns around 1.4 milion shares of DraftKings worth $88.1 million. Ark Fintech Innovation ETF (NYSE: ARKF) owns around 546,000 shares of DraftKings worth $33.8 million. DraftKings represents around 1.2% and 0.8% of ARKW and ARKF, respectively. Price Action: Shares of DraftKings finished the week down 6.24% at $59.52. Related Link: DraftKings And Dish Network Partner On Sports Betting, TV Integration See more from BenzingaClick here for options trades from BenzingaFuboTV Shares Pop On Caesars Partnership, Access To Additional States For Sports BettingHorizon Acquisition Corp SPAC Jumps 20% On Potential Sportradar Merger© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

  • Cathie Wood Shares Thoughts On Nano Dimension

    Ark Funds CEO and Founder Cathie Wood joined Benzinga’s “Raz Report” last week and discussed the history of Ark Funds. Wood also shared some of the reasons why Ark Funds owns several positions. Wood on Nano Dimension: Several of the Ark Funds ETFs hold positions in Nano Dimension (NASDAQ: NNDM). “Originally it used to call itself a 3D printed circuit board company,” Wood said. Now, Nano Dimension has broadened the view of itself into a 3D-printed-technology device company, she said. One of the important things about the Nano Dimension story is their contracts they are winning from defense agencies. “We always look for where the defense is putting their money,” Wood said. Wood said she is very impressed with new management at Nano Dimension and points out that the founder is still very involved. Ark Funds: The Ark Next Generation Internet ETF (NYSE: ARKW) owns over 5.8 million shares of Nano Dimension worth $45.8 million. The Ark Autonomous Technology & Robotics ETF (NYSE: ARKQ) owns over 7.1 million shares of Nano Dimension worth $55.4 million. Nano Dimension represents 0.6% and 1.6% of ARKW and ARKQ respectively. Related Link: 15 Big Ideas In Disruptive Innovation According To Cathie Wood’s Ark Funds See more from BenzingaClick here for options trades from BenzingaChamath Palihapitiya's 14 SPAC, PIPE Deals: Tracking Lifetime Performance — And The Past Week'sChamath Palihapitiya Shares Lessons Learned After Tough Week For SPACs© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

  • Chamath Palihapitiya Shares Lessons Learned After Tough Week For SPACs

    The last week has been a tough one for investors in many growth stocks. SPACs is one segment that was hit particularly hard. Lessons Learned From Palihapitiya: SPAC King Chamath Palihapitiya shared on Twitter Inc (NYSE: TWTR) how much he lost in the week and his thoughts on the SPAC market. “It’s been a super tough week for me and I’m sure a super tough week for some of you as well. Here is how I’m doing after Friday and what I’ve learned...” Palihapitiya tweeted. The investor broke down his lessons learned during the week as follows: “The first thing I tried to do yesterday was take a step back and try to see the bigger picture,” he said. Palihapitiya went on to say that March 2020 could be a guide as markets were down 20% then. Is this current market environment the same or different? Palihapitiya asks. He said he looked at his relative performance vs the S&P500, which breaks down as 3.6% compared to 2.3%, or 56% above the benchmark. He said he's not a "huge fan" of these numbers. “I re-questioned my goals and concluded my strategic view is still right: that inequality and climate change investments are a once in a lifetime opportunity to make hundreds of billions of dollars AND do the right thing," he said. “I freed up some capital by selling some shares in $SPCE so I can keep investing at scale without impacting my pace and strategic view.” Palihapitiya added that he hated selling the shares but had to do it after his balance sheet shrank by nearly $2 billion during the week. Palihapitiya also said he has not sold any shares of any other SPAC he’s launched. He went on to say that investing is hard, he is not perfect, and he is trying to learn just like his audience and followers on Twitter. “Be resilient and keep fighting,” he said. Markets are volatile and unforgiving, Palihapitiya added. Companies that do valuable things tend to see their value reflected in gains. “Find a way to make sure you are comfortable with what you own and if not, don’t be afraid to make changes. Prices are temporary but your peace of mind should not be,” he said. Palihapitiya ended his tweet with the Persian adage: “This too shall pass.” Related Link: 5 Things You Might Not Know About Chamath Palihapitiya Sale of Virgin Galactic Stock: The tweet from Palihapitiya came after he was in the news Friday for selling his personal stake in Virgin Galactic Holdings (NYSE: SPCE). Palihapitiya sold 6.2 million shares for around $211 million, according to Business Insider. It follows a similar sale in December. Palihapitiya still owns 15.8 million shares in Virgin Galactic through Social Capital Hedosophia, the company that Palihapitiya and partner Ian Osborne used to take the space tourism company public via SPAC. “I sold 6 million shares for $200 million, which I am planning to redirect into a large investment I am making towards fighting climate change,” Palihapitiya told Business Insider in an emailed statement. The investment will be made public in the next few months. It’s been a super tough week for me and I’m sure a super tough week for some of you as well. Here is how I’m doing after Friday and what I’ve learned... pic.twitter.com/fX5YHdqBv6 — Chamath Palihapitiya (@chamath) March 6, 2021 Disclosure: Author is long shares of SPCE. See more from BenzingaClick here for options trades from Benzinga3 Former SPACs Report Earnings: What Fisker, Velodyne Lidar, Virgin Galactic Investors Should Know© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

  • JPMorgan Posts 34 Blockchain Jobs as It Beefs Up JPM Coin

    A search for “blockchain” on JPMorgan’s career pages actually brings up 56 open positions, with 34 including the tech in the job title.

  • Not all your money belongs to you: Profits are rising in IRAs and 401(k)s, but so are future taxes

    Putting money into retirement accounts on a pretax basis doesn't mean you will avoid paying Uncle Sam eventually. Here's what to know.

  • Roblox goes public, inflation data: What to know in the week ahead

    This week, investors will be eyeing new inflation data, which will offer a look at whether prices have already begun to creep up as some have feared ahead of a major economic reopening. A highly anticipated direct listing for the vide0 game company Roblox is also on deck.

  • Gold Price Futures (GC) Technical Analysis – Strong Move Over $1711.70 Could Mean Gold Hit Bottom on Friday

    The direction of the April Comex gold market on Monday is likely to be determined by trader reaction to the major Fibonacci level at $1711.70.

  • Biggest Players in the Short-Selling Game Are Getting a Pass

    (Bloomberg) -- It’s in the air again, on Reddit, in Congress, in the C-suite: Hedge funds that get rich off short-selling are the enemy. The odd thing is, the biggest players in the game are getting a pass.Those would be the asset managers, pension plans and sovereign wealth funds that provide the vast majority of securities used to take bearish positions. Without the likes of BlackRock Inc. and State Street Corp., the California Public Employees’ Retirement System and the Kuwait Investment Authority filling such an elemental role, investors such as Gabe Plotkin, whose Melvin Capital Management became a piñata for day traders in the GameStop Corp. saga, wouldn’t have shares to sell short.“Anytime we short a stock, we locate a borrow,” Plotkin said Feb. 18 at the House Financial Services Committee hearing on the GameStop short squeeze.There’s plenty to choose from. As of mid-2020, some $24 trillion of stocks and bonds were available for such borrowing, with $1.2 trillion in shares -- equal to a third of all hedge-fund assets -- actually out on loan, according to the International Securities Lending Association.It’s a situation that on the surface defies logic. Given the popular belief that short sellers create unjustified losses in some stocks, why would shareholders want to supply the ammunition for attacks against their investments? The explanation is fairly straight forward: By loaning out securities for a small fee plus interest, they can generate extra income that boosts returns. That’s key in an industry where fund managers are paid to beat benchmarks and especially valuable in a world of low yields.The trade-off is simple: For investors with large, diversified portfolios, a single stock plummeting under the weight of a short-selling campaign has little impact over the long run. And in the nearer term, the greater the number of aggregate bets against a stock -- the so-called short interest -- the higher the fee a lender can charge.In the case of GameStop, short interest was unusually high and shares on loan were generating an annualized return of 25% to 30%, Ken Griffin testified at the Feb. 18 hearing. Griffin operates a market maker, Citadel Securities, as well as Citadel, one of the world’s largest hedge funds.“Securities lending is a way for long holders to generate additional alpha,” said Nancy Allen of DataLend, which compiles data on securities financing. “Originally, it was a way to cover costs, but over the last 10 to 15 years it’s become an investment function.”Not everyone is comfortable with the inherent conflict. In December 2019, Japan’s $1.6 trillion Government Pension Investment Fund stopped lending its international stock holdings to short sellers, calling the practice inconsistent with its responsibilities as a fiduciary. At the time, the decision cost GPIF about $100 million a year in lost revenue.The U.S. Securities and Exchange Commission has regulated short-selling since the 1930s and polices the market for abuses such as naked shorting, which involves taking a short position without borrowing shares. Proponents of legal shorting argue that its use enhances liquidity, improves pricing and serves a critical role as a bulwark against fraud and hype.Chief executives, whose pay packages often depend on share performance, routinely decry short sellers as vultures. More recently, shorting has come under fire in the emotionally charged banter on Reddit’s WallStreetBets forum. Some speculators ran up the prices of GameStop, AMC Entertainment Holdings Inc. and other meme stocks in January to punish the hedge funds that bet against them, and they delighted when the rampant buying led to bruising losses at Melvin, Maplelane Capital and Citron Research.Many of the key actors in the GameStop frenzy testified at the Feb. 18 hearing. Plotkin was grilled by committee members over Melvin’s short position. Citadel’s Griffin and others faced broader questions about short-selling. Yet no one asked about the supply of borrowed shares and there were no witnesses called from the securities-lending industry.There’s a symbiotic relationship between hedge funds and the prime-brokerage units of Wall Street firms, much of it built on securities lending. Prime brokers act as intermediaries, sourcing stocks and bonds for borrowers who want to short them and facilitate the trades. According to DataLend, securities lending generated $2.9 billion of broker-to-broker revenue in 2020, almost the same as in 2019.Demand for short positions was already expected to drop as stock prices surged to all-time highs. Now, with the threat of retribution from the Reddit crowd, it may weaken even further. Griffin said he has “no doubt” there’ll be less short-selling as a consequence of the GameStop squeeze.“I think the whole industry will have to adapt,” Plotkin said at the hearing. “I don’t think investors like myself want to be susceptible to these types of dynamics.”This could not only threaten the dealers who broker stock lending but also the holders who supply the securities and share in the revenue. They reaped $7.7 billion globally in 2020, down from a record of almost $10 billion in 2018, according to DataLend. Lending fees increased by 4.2% on a year-over-year basis in February after the GameStop onslaught, DataLend says.While securities lending accounted for $652 million, or just 4%, of BlackRock’s revenue in the fourth quarter of 2020, there’s little cost involved and the risks are low because borrowers have to put up collateral that equals or exceeds the value of the loan. At both BlackRock and State Street Corp., the second-largest custody bank, the value of securities on loan as of Dec. 31 jumped at least 20% from a year earlier, to $352 billion and $441 billion, respectively.“Every little bit counts with indexes,” said John Rekenthaler, vice president of research at Morningstar. “You’re scraping nickels off the street, but there’s a whole lot of nickels.”Others could take a hit, too. Just as Robinhood Markets is able to offer zero-commission trades by selling its order flow to Citadel and other market makers, asset managers typically pass on some of their securities-lending revenue as a type of client rebate.“It’s very important to remember that institutional investors earn substantial returns from participating in the securities-lending market,” Citadel’s Griffin said at the GameStop hearing. “That accrues to the benefit of pension plans, of ETFs, of other pools of institutional lending that participate in the securities lending market.”(Adds data on lending fees after the short-interest chart.)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.

  • AT&T, Chevron, Oracle, Verizon, T-Mobile and Other Stocks for Investors to Watch This Week

    The telecom companies host investor days, along with Cigna and Chevron. Plus, earnings, consumer and producer price indexes, and an ECB meeting.